FDA Clarifies Skin Protectant Labeling, Ingredient Combination Options
This article was originally published in The Rose Sheet
Executive Summary
FDA endeavors to clarify the active ingredients manufacturers may combine in OTC skin protectant drug products and corresponding label requirements in draft guidance released Aug. 1